101 related articles for article (PubMed ID: 27418574)
1. Aberrant Expression of CUL4A Is Associated with IL-6/ STAT3 Activation in Colorectal Cancer Progression.
Ren W; Sun Z; Zeng Q; Han S; Zhang Q; Jiang L
Arch Med Res; 2016 Apr; 47(3):214-22. PubMed ID: 27418574
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
3. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
[TBL] [Abstract][Full Text] [Related]
4. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
[TBL] [Abstract][Full Text] [Related]
5. Activating IL-6/STAT3 Enhances Protein Stability of Proteasome 20S
Ren W; Zhang X; Li Q; Pu C; Zhang D
Biomed Res Int; 2022; 2022():4250013. PubMed ID: 35615012
[TBL] [Abstract][Full Text] [Related]
6. Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.
Ren W; Shen S; Sun Z; Shu P; Shen X; Bu C; Ai F; Zhang X; Tang A; Tian L; Li G; Li X; Ma J
Cancer Lett; 2016 Jun; 375(2):209-220. PubMed ID: 26965998
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
Chu Q; Shen D; He L; Wang H; Liu C; Zhang W
Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075
[TBL] [Abstract][Full Text] [Related]
8. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L
Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257
[TBL] [Abstract][Full Text] [Related]
9. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis.
Heichler C; Scheibe K; Schmied A; Geppert CI; Schmid B; Wirtz S; Thoma OM; Kramer V; Waldner MJ; Büttner C; Farin HF; Pešić M; Knieling F; Merkel S; Grüneboom A; Gunzer M; Grützmann R; Rose-John S; Koralov SB; Kollias G; Vieth M; Hartmann A; Greten FR; Neurath MF; Neufert C
Gut; 2020 Jul; 69(7):1269-1282. PubMed ID: 31685519
[TBL] [Abstract][Full Text] [Related]
10. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
[TBL] [Abstract][Full Text] [Related]
11. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
12. Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3.
Wu A; Fang D; Liu Y; Shi X; Zhong Z; Zhou B; Ye L; Sun X; Jiang L
Theranostics; 2023; 13(14):4730-4744. PubMed ID: 37771783
[No Abstract] [Full Text] [Related]
13. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.
Räsänen K; Lehtinen E; Nokelainen K; Kuopio T; Hautala L; Itkonen O; Stenman UH; Koistinen H
Mol Carcinog; 2016 Dec; 55(12):2010-2023. PubMed ID: 26663388
[TBL] [Abstract][Full Text] [Related]
15. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling.
Zhang X; Hu F; Li G; Li G; Yang X; Liu L; Zhang R; Zhang B; Feng Y
Cell Death Dis; 2018 Jan; 9(2):25. PubMed ID: 29348540
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZEB1-AS1 expression predicts progression and poor prognosis of colorectal cancer.
Fu J; Cui Y
Int J Biol Markers; 2017 Oct; 32(4):e428-e433. PubMed ID: 28967064
[TBL] [Abstract][Full Text] [Related]
17. miR‑377 targets CUL4A and regulates metastatic capability in ovarian cancer.
Yu R; Cai L; Chi Y; Ding X; Wu X
Int J Mol Med; 2018 Jun; 41(6):3147-3156. PubMed ID: 29512715
[TBL] [Abstract][Full Text] [Related]
18. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
[TBL] [Abstract][Full Text] [Related]
19. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
20. IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor.
Kim B; Seo Y; Kwon JH; Shin Y; Kim S; Park SJ; Park JJ; Cheon JH; Kim WH; Il Kim T
Mol Carcinog; 2021 Mar; 60(3):188-200. PubMed ID: 33544929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]